Correlation between serum Urocortin-1 and α-Enolase in endometriosis: insights into a potential stress–metabolism signalling axis

Zainab Basil Jabbar, Suhaila Fadhil Al-Shaikh, Khawla A. Shemran
In: Middle East Fertility Society Journal · 2026 · vol. 31(1) · doi:10.1186/s43043-026-00338-w · W7226021035
OA: diamond CC0
🔓 Open OA copy View on OpenAlex View at publisher

Abstract

Abstract Background Endometriosis affects approximately 10% of women globally, with diagnostic delays often exceeding 8 years. Urocortin-1 (UCN-1) and alpha-enolase (ENO1) have each been independently implicated in its pathobiology, but their co-regulatory relationship in circulation remains poorly understood. This study aimed to quantify serum UCN-1, ENO1, and MMP-9 in patients versus controls, characterise the ENO1–UCN-1 correlation, and evaluate the independent diagnostic contribution of these biomarkers. Results Principal biomarkers were significantly elevated in patients (MMP-9: p = 0.015; ENO1: p = 0.040; UCN-1: p = 0.021). A pivotal finding was the very strong positive correlation between serum ENO1 and UCN-1 ( r = 0.91, 95% CI 0.853–0.945; p < 0.001), suggesting strong co-regulation. Both markers exhibited significant stage-dependent escalation ( p < 0.001). In multivariate logistic regression adjusted for age and BMI, UCN-1 emerged as a strong independent predictor (aOR = 4.564; 95% CI: 1.083–19.227; p = 0.039), while ENO1 was not independently predictive (aOR = 0.868; p = 0.451) due to high collinearity with UCN-1 (VIF = 5.82). The combined panel (UCN-1 + ENO1 + MMP-9) achieved AUC = 0.717 (bootstrap-corrected 0.701; 95% CI 0.611–0.789). Conclusions The r = 0.91 correlation provides preliminary serum-level evidence consistent with a hypothesised stress–metabolism axis, in which UCN-1-mediated signalling may be associated with glycolytic reprogramming (ENO1), putatively via PI3K–Akt and HIF-1α, although the intracellular steps were not measured in this study and the cascade remains hypothesis-generating only. ENO1 is not an independent biomarker of endometriosis in this dataset; its apparent contribution is fully captured by UCN-1 due to strong co-regulation. The combined UCN-1/ENO1/MMP-9 panel is NOT ready for clinical use: the AUC of 0.717 falls well below clinically deployable thresholds (typically AUC ≥ 0.85–0.90), and prospective external validation in larger, multi-centre cohorts — together with direct mechanistic confirmation — is mandatory before any clinical adoption can be considered.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (29)

Source provenance

openalex
last seen: 2026-11-15T06:03:07.880986+00:00
License: CC0 · commercial use OK